ALIMG Stock Overview
DMS Imaging SA engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
DMS Imaging SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.018 |
52 Week High | €0.026 |
52 Week Low | €0.002 |
Beta | 0.49 |
1 Month Change | -12.20% |
3 Month Change | -23.40% |
1 Year Change | -27.42% |
3 Year Change | -91.20% |
5 Year Change | -98.68% |
Change since IPO | -99.73% |
Recent News & Updates
DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward
Dec 21DMS Imaging SA's (EBR:DMSIM) Subdued P/S Might Signal An Opportunity
Jun 15Here's Why DMS Imaging (EBR:DMSIM) Can Manage Its Debt Responsibly
Dec 29Shareholder Returns
ALIMG | BE Biotechs | BE Market | |
---|---|---|---|
7D | -5.3% | 4.3% | 3.5% |
1Y | -27.4% | -2.7% | -2.4% |
Return vs Industry: ALIMG underperformed the Belgian Biotechs industry which returned -1.1% over the past year.
Return vs Market: ALIMG underperformed the Belgian Market which returned -1% over the past year.
Price Volatility
ALIMG volatility | |
---|---|
ALIMG Average Weekly Movement | 10.3% |
Biotechs Industry Average Movement | 7.4% |
Market Average Movement | 3.6% |
10% most volatile stocks in BE Market | 7.0% |
10% least volatile stocks in BE Market | 2.5% |
Stable Share Price: ALIMG's share price has been volatile over the past 3 months.
Volatility Over Time: ALIMG's weekly volatility has decreased from 18% to 10% over the past year, but is still higher than 75% of Belgian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 118 | Frank Hazevoets | https://www.dms-imaging.com |
DMS Imaging SA engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as ASIT Biotech S.A. and changed its name to DMS Imaging SA in February 2022.
DMS Imaging SA Fundamentals Summary
ALIMG fundamental statistics | |
---|---|
Market cap | €26.81m |
Earnings (TTM) | -€878.00k |
Revenue (TTM) | €39.66m |
0.7x
P/S Ratio-30.5x
P/E RatioIs ALIMG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALIMG income statement (TTM) | |
---|---|
Revenue | €39.66m |
Cost of Revenue | €23.02m |
Gross Profit | €16.64m |
Other Expenses | €17.52m |
Earnings | -€878.00k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Apr 30, 2024
Earnings per share (EPS) | -0.00059 |
Gross Margin | 41.96% |
Net Profit Margin | -2.21% |
Debt/Equity Ratio | 139.0% |
How did ALIMG perform over the long term?
See historical performance and comparison